AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.

The information is contained in the page "Update on hepatitis C" accessible through the box "Related links".

Published on: 20 January 2025